medigraphic.com
ISSN 1561-2961 (Print)

2012, Number 4

<< Back

Rev Cuba Enf 2012; 28 (4)

Risk perception of nurses in patient care living with HIV-AIDS

Olivera JJM, de la Rúa ME, Gracia NA, Ramírez OAM

Language: Spanish
References: 17
Page: 521-531
PDF size: 123.26 Kb.


ABSTRACT

We performed a descriptive, quali-quantitative, cross-sectional and prospective in order to evaluate the effect of risk perception in nursing care in patient living with HIV-AIDS. The universe was 3067 nurses (as) being the sample of 613 nurses (as) representing 20% of the universe, with the inclusion criteria were selected personnel work directly linked to welfare and represented different occupational categories. Such analysis indicated that the percent reflected a failure to collect was 18.4%, predominantly technical category to 41.5%. Regarding compliance to security incidents and the use of devices located, 5.5% is not taken into account and assumed to relate as professional categories, basic nurses accounted for 7.3% and was followed for graduates 6.2%. The 25.3% of the sample have had accidents or incidents that lead to risk exposure. It is reflected in the analysis of the perception of being contaminated by 24.6%, although it does not feel that affects the individual patient or supposedly healthy.


REFERENCES

  1. Trujillo JRC, Ramírez Rodríguez RA, Rogers M, Candanosa McCann P, Ancer Rodriguez J, Essex M. La Neuroinmunopatogénesis del VIH. Rev Mex Neuroci 2001; 2(5) : 259-267.

  2. ONUSIDA/OMS 2005. Resumen mundial de la epidemia de VIH/SIDA. Diciembre 2005. ONUSIDA-OMS/ 05.1-104.

  3. Epidemiología del VIH/SIDA en México en el Año 2005. Centro Nacional para la Prevención y Control del VIH/SIDA (CENSIDA). Secretaría de Salud/ México. Disponible: http:/www.salud.gob.mx/conasida. [Fecha de acceso Noviembre de 2006].

  4. Benson CA, Kaplan JE, Masur H, Pau A, Holmes KK. Treating Opportunistic Infections Among HIV-Infected Adults and Adolescents. MMWR. December 17, 2004; 53(RR15):1-112. Disponible en: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5315a1.htm.

  5. Microsoft ® Encarta ® 2009. © 1993-2008

  6. Brooks G, Butel J, Morse S. Microbiología médica de Jawetz, Meinick y Adelberg. XVII edición en español. México D. F. Editorial El Manual Moderno. 2002: 461-466.

  7. Nixon DE, McVoy MA. Terminally Repeated Sequences on a Herpesvirus Genome Are Deleted following Circularization but Are Reconstituted by Duplication during Cleavage and Packaging of Concatemeric DNA. Journal of Virology. 2002; 76( 4): 2009-13.

  8. Prieto Prieto J. Historia en Sida, crónica y protagonistas Disponible URL: http://www.sidalava.org/WEBcastellano/2_vih_historia.htm [fecha de acceso Noviembre de 2006]

  9. Conde-Gonzalez C J, Lazcano-Ponce E, Hernandez-Giron C, Juárez-Figueroa L, Smith JS, Hernandez-Avila M. Seroprevalencia de la infecciÓn por el virus herpes simplex tipo 2 en tres grupos poblacionales de la Ciudad de México. Salud Pública de México. 2003; 45(supl 5): S608-S616.

  10. Olmos-Olmos EM, Furman Rzonzew P, Torres Martínez BZ. Herpes genital FEPAFEM -Guías de Urgencias. Cap IV. 2007: 1079-82.

  11. Wald A, Link K. Risk of human immunodeficiency virus infection in herpes simplex virus infection in herpes simplex virus type 2 _ seropositive persons: A meta-analysis. J Infect Dis. 2002; 185: 45-52.

  12. Howard M, Sellors JW, Jang D, Robinson NJ, Fearon M, Kaczorowski J, Chernesky M. Regional Distribution of Antibodies to Herpes Simplex Virus Type 1 (HSV-1) and HSV-2 in Men and Women in Ontario, Canada. J Clin Microbiol. 2003;January; 41(1): 84-89.

  13. Valls Sánchez de Puerta E. Seguimiento de recién nacidos de riesgo infeccioso. Vox Pediátrica. 2000; 8(2):21-6.

  14. Mohar A, Volkow P, Sanchez-Mejorada G, Sada E, Soto JL, Pérez F, Ruiz-Palacios G. Sida y neoplasias en México. Salud Pública de México. 1995;37(6): 533-38.

  15. Gatell JM, Clotet B, Podzamcer D, Miró JM, Mallolas J, eds. Guía Practica del SIDA. Clínica, diagnostico y tratamiento. 6ª ed. Barcelona: Masson-Salvat; 2000.

  16. Guidelines for the Management of Health-Care Worker Exposures to HIV and Recommendations for Postexposure Prophylaxis. [Consulta 24 de Julio del 2000].MMWR 1998; 47 (RR-7): 1-28. URL disponible en: http://www.cdc.gov/epo/mmwr/preview/mmwrhtml /00052722.htm.

  17. Carpenter CC, Cooper DA, Fischl MA, Gatell JM, Gazzard BG, Hammer SM, et al. Antiretroviral Therapy in Adults Updated Recommendations of the International AIDS Society-USA Panel . JAMA. 2000; 283:381-390.




2020     |     www.medigraphic.com